H. Froehlich's Profile

Role	Title	Level	Year	L/R
🐜	Platelet-to-Lymphocyte Ratio: A Novel Marker for Critical Limb Ischemia in Peripheral Arterial Occlusive Disease Patients 11 auth. T. Gary, M. Pichler, K. Belaj, F. Hafner, A. Gerger, H. Froehlich, ... P. Eller, P. Rief, G. Hackl, E. Pilger, M. Brodmann	8	2013	8 🐜
🐜	Neutrophil-to-Lymphocyte Ratio and Its Association with Critical Limb Ischemia in PAOD Patients 9 auth. T. Gary, M. Pichler, K. Belaj, F. Hafner, A. Gerger, H. Froehlich, ... P. Eller, E. Pilger, M. Brodmann	6	2013	6 🐜
🐜	Percutaneous transluminal angioplasty versus primary stenting in infrapopliteal arteries in critical limb ischemia. 7 auth. M. Brodmann, H. Froehlich, A. Dorr, Thomas Gary, R. Portugaller, Hannes Deutschmann, ... E. Pilger	5	2011	5 🐜
🐜	Endothelial Dysfunction and Brachial Intima-Media Thickness: Long Term Cardiovascular Risk with Claudication Related to Peripheral Arterial Disease: A Prospective Analysis 10 auth. F. Hafner, Andreas Kieninger, A. Meinitzer, T. Gary, H. Froehlich, E. Haas, ... G. Hackl, P. Eller, M. Brodmann, G. Seinost	5	2014	5 🐜
🐜	Asymptomatic deep vein thrombosis and superficial vein thrombosis in ambulatory cancer patients: impact on short-term survival 11 auth. Thomas Gary, K. Belaj, K. Steidl, Martin Pichler, F. Eisner, H. Stöger, ... F. Hafner, H. Froehlich, Hellmut Samonigg, E. Pilger, M. Brodmann	5	2012	5 🐜
🐬	Intra-arterial injection, a rare but serious complication of sclerotherapy F. Hafner, H. Froehlich, Thomas Gary, M. Brodmann	4	2013	4 🐬
🐜	Endothelial function and carotid intima‐media thickness in giant‐cell arteritis 7 auth. F. Hafner, E. Haas, K. Belaj, H. Froehlich, T. Gary, P. Eller, ... M. Brodmann	4	2014	4 🐜
🐜	Neointimal Hyperplasia after Silverhawk Atherectomy versus Percutaneous Transluminal Angioplasty (PTA) in Femoropopliteal Stent Reobstructions: A Controlled, Randomized Pilot Trial 10 auth. M. Brodmann, P. Rief, H. Froehlich, A. Dorr, T. Gary, P. Eller, ... F. Hafner, H. Deutschmann, G. Seinost, E. Pilger	4	2013	4 🐜
🐜	Simvastatin Efficiently Lowers Small LDL-IgG Immune Complex Levels: A Therapeutic Quality beyond the Lipid-Lowering Effect 14 auth. G. Hörl, H. Froehlich, U. Ferstl, G. Ledinski, J. Binder, G. Cvirn, T. Stojaković, M. Trauner, C. Koidl, E. Tafeit, ... K. Amrein, H. Scharnagl, G. Jürgens, S. Hallström	4	2016	4 🐜